L-Hydroxyproline Powder: Specifications and Bulk Supply

White crystalline L-hydroxyproline powder with technical specifications and bulk packaging for B2B formulation projects
Table of Contents

L-hydroxyproline powder is a crystalline amino acid ingredient supplied for specialty nutrition blends, capsules, tablets, powder systems and selected formulation projects. Its chemical identity is trans-4-hydroxy-L-proline, CAS 51-35-4.

For B2B buyers, assay is only the starting point. Commercial approval should also consider chemical identity, stereochemistry, related substances, moisture, particle-size distribution, microbiological quality, heavy metals, production route and batch documentation.

Essencefield supports specification matching, representative samples, document review, additional testing coordination and recurring supply planning. Buyers can review the current L-hydroxyproline powder product information before requesting a sample or quotation.

L-Hydroxyproline Powder Supply Overview

ItemTypical or customizable supply information
Product nameL-Hydroxyproline Powder
Chemical identitytrans-4-Hydroxy-L-proline
CAS number51-35-4
Molecular formulaC5H9NO3
Molecular weight131.13 g/mol
AppearanceWhite to off-white crystalline powder
Typical assay options≥98.5% to ≥99.5%, according to the approved specification and method
Standard formNormally carrier-free powder
Typical particle size60–100 mesh; customized distribution may be discussed
Production routeConfirmed for the selected source or batch
Non-animal optionAvailable when supported by source and route documents
Typical shelf life24 months under the approved packaging and storage conditions
Sample optionsCommonly 100 g, 500 g or 1 kg
Commercial packagingTypically 25 kg in a lined fiber drum or carton
Typical MOQUsually 25 kg, subject to specification and packaging
Typical lead timeApproximately 7–15 business days for available standard material
DocumentsCOA, TDS, SDS, specification and applicable declarations

These values are published supply references, not guaranteed conditions for every order. The approved specification, commercial quotation and lot-specific Certificate of Analysis are the controlling documents for procurement.

Chemical Identity and Material Differentiation

L-hydroxyproline is an optically active form of 4-hydroxyproline with an L-trans configuration. The PubChem compound record identifies its molecular formula, molecular weight and CAS number. The European Bioinformatics Institute’s ChEBI entry further defines trans-4-hydroxy-L-proline by its stereochemical identity.

Stereochemistry matters because compounds with the same molecular formula are not automatically interchangeable. An appropriate identity method and, where required, specific optical rotation help establish that a commercial batch corresponds to the intended form.

L-hydroxyproline versus L-proline

L-proline and L-hydroxyproline are related but distinct raw materials.

PropertyL-ProlineL-Hydroxyproline
CAS number147-85-351-35-4
Molecular formulaC5H9NO2C5H9NO3
Structural distinctionNo hydroxyl group on the ringContains an additional hydroxyl group
Procurement implicationSeparate amino acidRequires an independent specification and identity test

A quotation or COA that refers only to “proline” does not establish that the supplied material is trans-4-hydroxy-L-proline.

L-hydroxyproline versus collagen powder

Collagen and hydrolyzed collagen are protein or peptide mixtures containing several amino acids. L-hydroxyproline powder is a defined, low-molecular-weight ingredient.

The distinction affects:

  • Formulation calculations;
  • Ingredient labeling;
  • Analytical methods;
  • Supplier qualification;
  • Quality specifications;
  • Finished-product claims.

A total hydroxyproline result for a collagen ingredient does not demonstrate an equivalent quantity of isolated free L-hydroxyproline.

Relationship with collagen

Hydroxyproline is associated with collagen because properly positioned hydroxyproline residues contribute to collagen triple-helix stability. Structural studies of collagen and collagen-model peptides support this biochemical relationship.

However, the presence of hydroxyproline in collagen does not independently prove that an isolated ingredient or finished product will deliver a specific skin, joint, wound-healing or anti-aging outcome. Such claims require evidence for the actual ingredient, use level and formulation.

Key Specifications and COA Review

A useful commercial specification connects chemical identity, purity and physical performance.

The ICH Q6A guideline defines a specification as a list of tests, analytical procedures and acceptance criteria. Although developed for pharmaceutical substances and products, this framework illustrates why an ingredient name and headline assay do not form a complete quality standard.

Core quality parameters

ParameterProcurement relevance
AppearanceDetects visible color or physical variation
IdentificationConfirms chemical identity
AssayMeasures the main component under a defined method
Specific optical rotationSupports stereochemical evaluation
Related substancesDetects process impurities or degradation products
Foreign amino acidsSupports amino acid purity assessment
Loss on dryingIdentifies moisture-related variation
Water activityHelps evaluate caking and storage risk
Residue on ignitionIndicates residual inorganic material
Residual solventsLinks impurity testing to the production route
Particle-size distributionInfluences flow, blending, filling and dissolution
Bulk densityAffects capsule volume and packaging calculations
FlowabilitySupports filling-line and dry-blend evaluation
Solution clarityRelevant to beverages and low-sediment systems
Microbiological limitsSupports ingestible-product quality control
Heavy metalsSupports customer and destination-market requirements

Essencefield’s published product information states that identification may use FTIR, HPLC retention time or another agreed method. Assay, specific rotation, related substances, foreign amino acids, moisture and physical-performance tests can be incorporated according to the customer-approved specification.

Why assay alone is insufficient

Two batches can report a similar assay while differing in:

  • Stereochemical identity;
  • Related-substance profile;
  • Moisture or water activity;
  • Particle size;
  • Bulk density;
  • Flowability;
  • Microbiological status;
  • Dissolution or solution clarity.

The analytical method also changes how a result should be interpreted. A selective chromatographic assay may distinguish the target compound from related substances more effectively than a non-specific method.

The reporting basis must also be clear. A result calculated on a dry basis is not directly equivalent to an as-is result unless moisture correction is considered.

A supplier comparison should therefore establish:

  • The assay method;
  • The reporting basis;
  • Whether related substances are measured separately;
  • Whether the method differentiates relevant impurities;
  • Whether the sample and commercial lot use the same release method.

Specific optical rotation

Specific optical rotation can support confirmation of the intended optical form, but the value is meaningful only when the test conditions are stated.

The method should define:

  • Solvent;
  • Sample concentration;
  • Temperature;
  • Wavelength;
  • Cell length;
  • Dry-basis correction where applicable.

A result reported only as “+27°” cannot be compared reliably with another supplier’s result when the concentration, solvent or temperature differs.

Specific rotation should support chemical identity testing rather than replace it.

Typical microbiological and heavy-metal controls

CategoryTypical published limit
Total plate count≤1,000 CFU/g
Yeast and mold≤100 CFU/g
E. coliNegative in 10 g
SalmonellaNegative in 25 g
Lead≤1.0 ppm
Arsenic≤1.0 ppm
Cadmium≤0.5 ppm
Mercury≤0.1 ppm

The final specification may apply different limits according to the destination market, dosage form, customer standard or manufacturing facility.

Four-step COA review

A lot-specific COA should be treated as a batch release record rather than a product brochure.

1. Confirm identity and batch details

Match the chemical name, CAS number, grade, material code, batch number and relevant manufacturing or testing dates.

2. Match results and methods with the approved specification

Check that every reported result corresponds to an agreed acceptance criterion and analytical procedure.

3. Review stereochemistry, impurities and contaminants

Evaluate specific rotation, related substances, foreign amino acids, residual solvents, microbiological results and heavy metals where applicable.

4. Compare the commercial batch with the approved sample

A lot may pass assay but still differ from the sample in moisture, particle size, flow, odor, color or solution clarity.

Essencefield’s raw-material quality process connects supplier qualification, specification approval, COA review, incoming inspection, release and batch traceability.

Production Route and Supporting Documents

The ingredient name does not reveal whether a batch is recovered from animal-derived material, converted from another intermediate or produced through a different route. The selected source and production route should therefore be documented.

Route selection may affect:

  • Non-animal or vegan positioning;
  • Starting-material traceability;
  • GMO declarations;
  • Allergen review;
  • BSE/TSE documentation;
  • Residual-solvent testing;
  • Related-substance limits;
  • Country-of-origin documentation.

Essencefield states that source and production route are confirmed for the selected batch. A non-animal option may be available when supported by the route declaration and source documents.

A typical qualification package may include:

  • Product specification;
  • Lot-specific COA;
  • Technical Data Sheet;
  • Safety Data Sheet;
  • Country-of-origin statement;
  • Production-route declaration;
  • Allergen statement;
  • GMO statement;
  • Vegan or animal-origin statement;
  • Gluten statement;
  • Irradiation statement;
  • Third-party laboratory report where required.

Document availability depends on the source, manufacturing site, commercial batch and requested testing scope. The testing and certification support page explains how technical documents, third-party reports and facility-specific certificates are handled for individual projects.

Application, Processing and Storage

A batch can comply with its chemical specification and still perform differently during manufacturing. Particle size, density, moisture, flow and dissolution should be evaluated under realistic processing conditions.

Solid dosage forms and dry blends

L-hydroxyproline powder may be evaluated for capsules, tablets, sachets, stick packs and functional premixes.

For capsules and automated filling, the most relevant physical attributes include:

  • Particle-size distribution;
  • Bulk and tapped density;
  • Flowability;
  • Moisture;
  • Blend uniformity.

A fine sample may not represent a commercial batch with a broader particle-size distribution. The difference can affect filling speed, weight consistency and powder segregation even when the assay remains unchanged.

Tablet projects should confirm that the complete formulation can be filled, compressed and disintegrated consistently. These properties cannot be predicted from the L-hydroxyproline assay alone.

In multicomponent blends, large differences in density or particle size can cause segregation during transport and filling. Representative pilot trials are therefore more useful than evaluating the raw material only in a laboratory container.

Beverage and food systems

L-hydroxyproline is generally described as water-soluble, but formulation suitability should be tested at the intended concentration.

Relevant variables include:

  • Water temperature;
  • Mixing time;
  • Finished-product pH;
  • Acids and minerals;
  • Solution clarity;
  • Insoluble matter;
  • Sediment after storage;
  • Taste and aftertaste.

A powder that dissolves in purified water may behave differently in an acidic, mineral-rich or high-solid beverage.

Ready-to-drink applications should be assessed after the intended thermal process and throughout the expected shelf life. Gummies and other heated food matrices require verification of the addition point, uniform distribution, sensory impact and finished-product stability.

Consumer-facing claims must also match the available evidence and destination-market rules. In the United States, the FDA guidance on structure/function claims explains the distinction between permitted structure/function statements and disease claims.

Packaging and storage

Commercial material is typically packed in a food-grade lined 25 kg drum or carton. Higher-barrier liners, smaller inner packs or desiccants may be considered for humid destinations or repeated container opening.

The powder should remain sealed in a cool, dry and light-protected area. Containers should be closed promptly after use and protected from high humidity and strong odors.

Storage conditions and shelf life should follow the approved product specification rather than a general website statement.

Supplier Qualification and Commercial Approval

A reliable sourcing process should connect the specification, representative sample, first commercial batch and repeat-order controls.

1. Define the project requirement

Confirm:

  • Application and dosage form;
  • Destination market;
  • Required assay and analytical method;
  • Production-route preference;
  • Particle-size requirement;
  • Microbiological and heavy-metal limits;
  • Packaging;
  • Documentation;
  • Trial quantity and annual forecast.

2. Review documents and a representative sample

The specification, representative COA, origin information and route declaration should be reviewed before sample approval.

Testing should focus on the characteristics that affect the actual project. A beverage developer may prioritize solution clarity and taste, while a capsule manufacturer may focus on density and flowability.

3. Approve the formulation and commercial lot

Use the representative sample for bench testing and pilot processing.

When the first commercial lot arrives, compare it with:

  • The approved specification;
  • The tested sample;
  • The expected physical properties;
  • The agreed document package.

A commercial batch that passes assay can still require investigation if moisture, flow or dissolution differs materially from the approved sample.

4. Monitor repeat supply

For recurring orders, track:

  • COA trends;
  • Source or route changes;
  • Specification revisions;
  • Particle-size variation;
  • Packaging condition;
  • Delivery performance.

Changes affecting identity, impurity profile or manufacturing performance should be reviewed before the revised material is accepted.

Bulk Supply Through Essencefield

Essencefield supports specification matching, representative samples, batch-document review, additional testing coordination and recurring supply planning for L-hydroxyproline powder projects.

Typical published commercial references include samples for formulation evaluation, 25 kg bulk packaging, a usual 25 kg MOQ and an estimated 7–15-business-day lead time for available standard material. Actual terms depend on the selected specification, source, stock position, additional testing, packaging and destination market.

The company’s B2B workflow is intended to help supplement brands, contract manufacturers, ingredient distributors and importers compare material requirements before placing a commercial order.

Request a Specification, Sample or Quote

A complete inquiry should include:

  • Application and destination market;
  • Required assay and test method;
  • Production-route or non-animal requirement;
  • Trial quantity and annual forecast;
  • Particle-size or physical-property requirements;
  • Packaging;
  • Required documents;
  • Expected delivery date.

Use the Essencefield contact page to submit an existing specification, formula, COA or supplier document and request the current specification, representative sample and bulk quotation.

Providing the technical and commercial requirements at the beginning of the inquiry makes it easier to determine whether the available source, testing package and supply conditions match the project.

Request a Manufacturing Quote

Please use the form below to share your ingredient requirements—product category, target application, desired specifications (e.g., assay/ratio, mesh size, carrier), and estimated order quantity. If you need OEM/private label, include dosage form and key label claims. We’ll route your request to the right team and recommend suitable ingredients, testing/documentation options, packaging, and lead times. You’ll receive indicative pricing, MOQ, and a sample/approval plan.

Picture of Essencefield Editorial Team | Ingredient Science, Quality & OEM Manufacturing

Essencefield Editorial Team | Ingredient Science, Quality & OEM Manufacturing

We publish technical guides for B2B sourcing and formulation of botanical ingredients, including typical COA/Spec ranges, risk-based testing plans, documentation, and OEM/private-label manufacturing. Content is reviewed to align with manufacturing feasibility, batch traceability, and quality control practices used for global export projects.

Reviewed By: Essencefield QA & Technical Team (Quality System)

Documents (on request): COA · TDS/Spec · SDS · Allergen/GMO statements · Regulatory declarations (market-dependent)

More Posts